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PROGRESS
It was decided to treat his rheumatoid disease with weekly injections of intramuscular gold in the hope of controlling his general condition and his diplopia. Unfortunately he developed such violent reactions to the injections in the form of rigors and joint pains that they had to be stopped after 6 weeks. Penicillamine was then cautiously introduced, but he soon developed diarrhoea and a rash, so therapy was discontinued. His rheumatoid disease was therefore controlled with indomethacin and aspirin.
As his diplopia persisted, in March 1978 he was given an orbital injection of 1 ml (40 mg) of methylprednisolone acetate (Depomedrone) over the superomedial aspect of the left globe. Some lessening of his diplopia and improvement in his Hess chart were noted, and therefore a week later a similar orbital injection was given on the right side. A month later the patient was symptomatically very much improved, experiencing diplopia only on extreme upward gaze. A Hess chart recorded on this occasion is shown in Fig. 2 .
Six months later his diplopia began to return and by March 1979 was no longer tolerable. Ocular examination and Hess chart (Fig. 3) showed a recurrence of his bilateral superior oblique tendon sheath syndrome. Orbital injections of I ml of 358 methylprednisolone acetate were given superomedially over each globe. Four weeks later he had improved greatly subjectively and objectively (Fig.  4) group.bmj.com on October 14, 2017 -Published by http://bjo.bmj.com/ Downloaded from dromes. The true sheath syndrome is always congenital and never disappears spontaneously. The simulated syndrome, however, may be congenital or acquired, may be intermittent and sometimes even undergo spontaneous recovery. The acquired simulated sheath syndrome has been described in association with ethmoiditis, orbital floor fractures, tucking of the superior oblique tendon, and rheumtoid arthritis.
Various surgical procedures designed to ameliorate the condition by weakening the superior oblique tendon have been reported.5 We describe the treatment of bilateral superior oblique tendon sheath syndromes with local injection of steroids in a patient with rheumatoid arthritis. As the patient improved both subjectively and objectively after each steroid injection, it seems unlikely that this was due to spontaneous recovery.
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